Debut Plus

₹263.8

▲ +0.79 +0.30%

As of 26 Oct 2026 · delayed

NSE Listed

Medicamen Biotech Limited (MEDICAMEQ)

Volume: 12,531Avg Vol 1W: 21,047.8Avg Vol 1M: 20,478.6552W Range:₹212.4₹447.65
NSE BSE www.medicamen.com AI Report
Key Ratios
Checked 11h ago
Market Cap₹374 Cr
Current Price₹263.8
Previous Close₹263.01
High / Low (52w)₹447.65 / ₹212.4
Volume12,531
Avg Vol (1W)21,047.8
Avg Vol (1M)20,478.65
Stock P/E33.33
Book Value₹208.66
Dividend Yield36%
ROE349.9%
ROA269.9%
Revenue (TTM)₹169 Cr
Revenue Growth-9.3%
Profit Margin5.35%
Total Debt₹4 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹7.7
P/B1.27
Debt / Equity0.17
50 DMA₹284.09
200 DMA₹276.46
Day change+0.30%
Price Chart
₹263.8▼ 25.30% · 1Y
₹416₹2203.6L
2025-10-27
2026-10-26

20-day avg volume: 20K shares

Pros
  • Healthy return on equity of 349.9%.
  • Pays a dividend yield of 36.0%.
  • Company is almost debt-free.
  • Revenue grew 12% YoY.
Quarterly Results
MetricMar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹30 Cr₹43 Cr₹47 Cr₹47 Cr₹61 Cr
EBITDA₹-2 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr
Net Profit₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹4 Cr
EPS1.471.181.561.213.28
Profit & Loss (Annual)
MetricMar 2017Mar 2018Mar 2019Mar 2020
Revenue₹83 Cr₹112 Cr₹123 Cr₹117 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹5 Cr₹10 Cr₹12 Cr₹12 Cr
EPS————
Balance Sheet
MetricMar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹279 Cr₹295 Cr₹297 Cr₹372 Cr
Total Liabilities₹85 Cr₹88 Cr₹84 Cr₹96 Cr
Equity₹193 Cr₹205 Cr₹212 Cr₹276 Cr
Total Debt₹26 Cr₹31 Cr₹34 Cr₹48 Cr
Cash Flow
MetricMar 2023Mar 2024Mar 2025Mar 2026
Operating₹-6 Cr₹-7 Cr₹-8 Cr₹-33 Cr
Investing₹-6 Cr₹-6 Cr₹-1 Cr₹-3 Cr
Financing₹29 Cr₹6 Cr₹-1 Cr₹64 Cr
Free Cash Flow₹-13 Cr₹-13 Cr₹-10 Cr₹-38 Cr
Shareholding
Promoter 62.54% Institutions 0% Public 37.46%
About Medicamen Biotech Limited

Healthcare · Drug Manufacturers - Specialty & Generic

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.

www.medicamen.com ↗
Shareholding Details

As of 2026-06-30

Promoter63%
FII—
DII—
Institutions0%
Public37%
Promoter Pledge—
No. of Shareholders—
Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Magellanic Cloud LimitedMcon Rasayan India Ltd.Multi Commodity Exchange of India Ltd.Marvel Decor LimitedGlobal Health LimitedMedi Assist Healthcare Services Ltd.Medi-Caps Ltd.Medico Remedies LimitedMedicamen Organics Ltd.Medistep Healthcare Ltd.Medplus Health Services Ltd.Meesho LimitedAll “M” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search